Want to see TSE:TELO full AI Analyst Report?
Telo Genomics Corp (TELO) Financial Statements
Telo Genomics Corp Financial Overview
Telo Genomics Corp's market cap is currently $5.02M. The company's EPS TTM is $-0.02; its P/E ratio is -2.17; Telo Genomics Corp has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Jun 26 | Sep 25 | Sep 24 | Jun 22 | Sep 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -86.56K | $ -14.45K | $ -39.54K | $ -33.11K | $ -62.23K |
| Operating Income | $ -2.19M | $ -2.70M | $ -2.72M | $ -2.82M | $ -1.25M |
| EBITDA | $ -2.10M | $ -2.69M | $ -2.67M | $ -2.78M | $ -1.01M |
| Net Income | $ -2.31M | $ -2.72M | $ -2.71M | $ -2.82M | $ -1.07M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 338.32K | $ 789.29K | $ 796.02K | $ 2.67M | $ 3.64M |
| Total Assets | $ 599.90K | $ 911.30K | $ 965.64K | $ 2.93M | $ 3.84M |
| Total Debt | $ 1.44M | $ 0.00 | $ 0.00 | $ 32.50K | $ 40.00K |
| Net Debt | $ 1.11M | $ -789.29K | $ -796.02K | $ -2.64M | $ -3.60M |
| Total Liabilities | $ 2.18M | $ 396.32K | $ 375.59K | $ 312.87K | $ 153.66K |
| Stockholders' Equity | $ -1.58M | $ 514.98K | $ 590.06K | $ 2.61M | $ 3.69M |
| Cash Flow | |||||
| Free Cash Flow | $ -1.61M | $ -2.33M | $ -2.46M | $ -2.70M | $ -1.11M |
| Operating Cash Flow | $ -1.59M | $ -2.33M | $ -2.46M | $ -2.63M | $ -1.10M |
| Investing Cash Flow | $ -18.75K | $ -3.25K | $ -5.12K | $ -69.06K | $ -9.31K |
| Financing Cash Flow | $ 1.16M | $ 2.33M | $ 587.05K | $ 2.68M | $ 3.83M |
Currency in CAD